These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

985 related items for PubMed ID: 19331235

  • 21. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
    Elbl L, Vásová I, Krejcí M, Navrátil M, Tomásková I, Jedlicka F, Chaloupka V, Mayer J, Vorlícek J.
    Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
    [Abstract] [Full Text] [Related]

  • 22. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
    Noordijk EM, Carde P, Dupouy N, Hagenbeek A, Krol AD, Kluin-Nelemans JC, Tirelli U, Monconduit M, Thomas J, Eghbali H, Aleman BM, Bosq J, Vovk M, Verschueren TA, Pény AM, Girinsky T, Raemaekers JM, Henry-Amar M.
    J Clin Oncol; 2006 Jul 01; 24(19):3128-35. PubMed ID: 16754934
    [Abstract] [Full Text] [Related]

  • 23. An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program.
    Klimo P, Connors JM.
    Semin Hematol; 1988 Apr 01; 25(2 Suppl 2):34-40. PubMed ID: 2456621
    [Abstract] [Full Text] [Related]

  • 24. Hodgkin's disease: summary of twenty years' experience.
    Mazza P, Bocchia M, Zinzani PL, Fiacchini M, Gherlinzoni F, Bandini G, Bendandi M, Frezza GP, Neri S, Barbieri E.
    Haematologica; 1992 Apr 01; 77(6):487-93. PubMed ID: 1283856
    [Abstract] [Full Text] [Related]

  • 25. CAV chemotherapy (CCNU, melphalan, etoposide) as salvage treatment for relapsing or resistant Hodgkin's disease.
    Brusamolino E, Castelli G, Pagnucco G, Orlandi E, Malagó D, Lazzarino M, Bernasconi C.
    Haematologica; 1990 Apr 01; 75(4):340-5. PubMed ID: 1703510
    [Abstract] [Full Text] [Related]

  • 26. Hodgkin's disease. A historical perspective.
    Avilés A, Díaz-Maqueo JC, Torras V, Ayala JR, Cortés HD.
    Arch Invest Med (Mex); 1991 Apr 01; 22(1):27-33. PubMed ID: 1726450
    [Abstract] [Full Text] [Related]

  • 27. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA, Leventhal B, Brecher ML, Marcus RB, Cantor A, Gieser PW, Ternberg JL, Behm FG, Wharam MD, Chauvenet AR.
    J Clin Oncol; 1997 Aug 01; 15(8):2769-79. PubMed ID: 9256118
    [Abstract] [Full Text] [Related]

  • 28. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P, Abate G, Fiore M, Di Finizio G, Frezza P, Scoppa G, Anania C, Coucourde F, Zarrilli D.
    J Chemother; 1989 Jul 01; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract] [Full Text] [Related]

  • 29. [The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials].
    Zittoun R, Eghbali H, Audebert A, Rojouan J, David B, Blanc CM, Hoerni B, Debray J.
    Bull Cancer; 1987 Jul 01; 74(2):151-7. PubMed ID: 2440504
    [Abstract] [Full Text] [Related]

  • 30. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P, Bonadonna G.
    Haematologica; 1998 Sep 01; 83(9):769-70. PubMed ID: 9825571
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis].
    Filatova LV, Plotnikova AA, Gershanovich ML, Semiglazova TIu.
    Vopr Onkol; 2013 Sep 01; 59(2):59-65. PubMed ID: 23814851
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Combination chemotherapy with alternating MOPP-ABVD in advanced Hodgkin's disease.
    Brusamolino E, Lazzarino M, Morra E, Inverardi D, Merante S, Castelli G, Canevari A, Dornini G, Bernasconi C.
    Haematologica; 1989 Sep 01; 74(2):173-9. PubMed ID: 2473013
    [Abstract] [Full Text] [Related]

  • 36. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
    Engert A, Schiller P, Josting A, Herrmann R, Koch P, Sieber M, Boissevain F, De Wit M, Mezger J, Duhmke E, Willich N, Muller RP, Schmidt BF, Renner H, Muller-Hermelink HK, Pfistner B, Wolf J, Hasenclever D, Loffler M, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 Oct 01; 21(19):3601-8. PubMed ID: 12913100
    [Abstract] [Full Text] [Related]

  • 37. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
    Hentrich M, Berger M, Wyen C, Siehl J, Rockstroh JK, Müller M, Fätkenheuer G, Seidel E, Nickelsen M, Wolf T, Rieke A, Schürmann D, Schmidmaier R, Planker M, Alt J, Mosthaf F, Engert A, Arasteh K, Hoffmann C.
    J Clin Oncol; 2012 Nov 20; 30(33):4117-23. PubMed ID: 23045592
    [Abstract] [Full Text] [Related]

  • 38. Hodgkin's disease: controversies and challenges for the future.
    Tura S, Canellos G, Goldstone A, Longo D, McMillan A, Urba W, Zinzani PL.
    Haematologica; 1991 Nov 20; 76(4):263-79. PubMed ID: 1724436
    [No Abstract] [Full Text] [Related]

  • 39. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Tsushita K, Utsumi M, Shimoyama M.
    Gan To Kagaku Ryoho; 1998 Dec 20; 25(14):2202-9. PubMed ID: 9881076
    [Abstract] [Full Text] [Related]

  • 40. [Cured from Hodgkin's disease].
    Brice P.
    Bull Cancer; 2002 Dec 20; 89(7-8):666-70. PubMed ID: 12206979
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.